Join Ross Lagoy and Marshall discussing CRISPR/Cas9 genome editing, developing critical platform technologies that accelerate drug discovery and how to connect the bench to automation. Ross is a Senior Scientist at Intellia Therapeutics working to establishing new technologies and analysis pipelines to help identify potential cures for patients living with genetic disease.
SLAS2026 International Conference & Exhibition
SLAS Europe 2026 Conference and Exhibition
